Screening mammography controversies: Resolved, partly resolved, and unresolved

Breast Journal

Volumn 11, Issue SUPPL. 1, 2005, Pages

  Feig, Stephen A ^a  

^a MOUNT SINAI HOSPITAL   (United States)

Author keywords

Breast cancer mortality; Mammography; Screening

Indexed keywords

AGING; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CARCINOMA IN SITU; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; HUMAN; MAMMOGRAPHY; PARAMETER; RADIATION EXPOSURE; RADIATION HAZARD; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; X RAY;

ADULT; AGED; BREAST NEOPLASMS; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED;

EID: 15944362540     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1075-122X.2005.217161.x     Document Type: Conference Paper

References (49)

1. Feig SA, D'Orsi CJ, Hendrick RE, et al. American College of Radiology guidelines for breast cancer screening. AJR Am J Roentgenol 1998;171:29-33.
2. Humphrey LL, Helfand M, Chan BKS, Woolf SH. Breast cancer screening: a summary of the evidence for the US. Preventive Services Task Force. Ann Intern Med 2002;137:347-60.
3. Shapiro S, Venet W, Strax P, Venet L. Periodic Screening for Breast Cancer: The Health Insurance Plan Project and its Sequelae: 1963-1986. Baltimore: John Hopkins University Press, 1988.
4. Tabar L, Vitak B, Chen H-H, et al. The Swedish Two-County Trial twenty years later. Radiol Clin N Am 2000;38:625-52.
5. Alexander FE, Anderson TJ, Brown HK, et al. 14 years of follow-up from the Edinburgh randomized trial of breast cancer screening. Lancet 1999;353:1903-8.
6. Andersson I, Aspegren K, Janzon L, et al. Mammographic screening trial. BMJ 1998;297:943-48.
7. Frisell J, Lidbrink E, Hellstrom L, Rutqvist LE. Follow-up after 11 years: update of mortality results in the Stockholm mammographic screening trial. Breast Cancer Res Treat 1997;45:263-70.
8. Bjurstam N, Bjorneld L, Warwick J, et al. The Gothenburg breast screening trial. Cancer 2003;97:2387-96.
9. Miller AB, To T, Baines CJ, Wall C. Canadian National Breast Screening Study -2:13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst 2000;92:1490-99.
10. Miller AB, Baines CJ, To T, Wall C. The Canadian National Breast Screening Study -1: Breast cancer mortality after 11-16 years of follow-up. A randomized screening trial of mammography in women age 40-49 years. Ann Intern Med 2002;137:305-12.
11. Kopans DB, Feig SA. The Canadian National Breast Screening Study: a critical review. AJR Am Roentgenol 1993;161:755-60.
12. Feig SA. Estimation of currently attainable benefit from mammographic screening of women aged 40-49 years. Cancer 1995;75:2412-19.
13. Feig SA. Determination of mammographic screening intervals with surrogate measures for women aged 40-49 years. Radiology 1994;193:311-14.
14. Feig SA. Increased benefit from shorter screening mammography intervals for women ages 40-49 years. Cancer 1997;80:2035-39.
15. Hendrick RE, Smith RA, Rutledge JH III, Smart CR. Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. Monogr Natl Cancer Inst 1997;33:87-92.
16. Chu KC, Smart CR, Tarone RE. Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial J Natl Cancer Inst 1988;80:1125-32.
17. Bjurstam N, Bjorneld L, Duffy SW, et al. The Gothenburg Breast Screening Trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization. Cancer 1997;80:2091-99.
18. Andersson I, Janzon L. Reduced breast cancer mortality in women under 50: updated results from the Malmo Mammographic Screening Program. Monogr Natl Cancer Inst 1997;22:63-68.
19. Feig SA. Screening mammography: effect of image quality on clinical outcome. AJR Am J Roentgenol 2002;178:805-7.
20. Feig SA. Effect of service screening mammography on population mortality from breast carcinoma. Cancer 2002;95:451-57.
21. Tabar L, Vitak B, Chen H-H, Yen M-F, Duffy SW, Smith RA. Beyond randomized trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer 2001;91:1724-31.
22. Duffy SW, Tabar L, Chen H-H, et al. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties: a collaborative evaluation. Cancer 2002;95:458-69.
23. Gotzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000;355:129-34.
24. Olsen O, Gotzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet 2001;358:1340-42.
25. Tabar L, Duffy SW, Yen M-F, et al. All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an endpoint. J Med Screen 2002;9:159-62.
26. Duffy SW, Tabar L, Smith RA. The mammographic screening trials: commentary on the recent work by Olsen and Gotzsche. CA Cancer J Clin 2002;52:68-71.
27. Feig SA. How reliable is the evidence for screening mammography? Recent Results Cancer Res 2002;163:129-39.
28. Feig SA. Adverse effects of screening mammography. Radiol Clin N Am 2004;42:807-19.
29. Feig SA, Hendrick RE. Radiation risk from screening mammography of women aged 40-49 years. Monogr Natl Cancer Inst 1997;22:119-24.
30. Rothenberg LN, Feig SA, Haus AG, et al. A guide to mammography and other breast imaging procedures. NCRP report no. 72. Bethesda, MD: National Council on Radiation Protection and Measurements, 2004.
31. Ries L, Eisner MP, Kosary C, et al. SEER Cancer Statistics Review, 1975-2000. Bethesda, MD: National Cancer Institute, 2003.
32. Sickles EA, Ominsky SH, Sollito RA, Galvin HB, Monticciolo DL. Medical audit of a rapid-throughput mammography screening practice: methodology and results of 27,114 examinations. Radiology 1990;175:323-27.
33. Kopans DB, Moore RH, McCarthy KA, et al. Positive predictive value of breast biopsy performed as a result of mammography. There is no abrupt change at age 50 years. Radiology 1996;200:357-60.
34. Ernster VL, Ballard-Barbash R, Bartow WE, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 2002;94:1546-54.
35. Smart CR, Byrne C, Smith RA, et al. Twenty-year follow-up of breast cancers diagnosed during the Breast Cancer Detection Demonstration Project. CA Cancer J Clin 1997;47:134-49.
36. Silverstein M. Non-invasive breast cancer: the dilemma of the 1990s. Obstet Gynecol Clin N Am 1994;21:639-58.
37. Ernster FL, Barclay J, Kerlikowske K, Grady D, Henderson IC. Incidence and treatment for ductal carcinoma in situ of the breast. JAMA 1996;275:913-18.
38. Fletcher SW. Why question screening mammography for women in their forties? Radiol Clin N Am 1995;33:1259-72.
39. Harris R. Variation of benefits and harms of breast cancer screening with age. Monogr Natl Cancer Inst 1997;22:139-45.
40. Ernster VL, Barclay J. Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma. Monogr Natl Cancer Inst 1997;22:151-56.
41. Feig SA. Ductal carcinoma in situ: implications for screening mammography. Radiol Clin N Am 2000;38:653-58.
42. Cady B. How to prevent invasive breast cancer. Detect and excise duct carcinoma in situ. J Surg Oncol 1998;69:60-62.
43. Yen M-F, Tabar L, Smith RA, Chen H-H, Duffy SW. Quantifying the potential problem of over-diagnosis of ductal carcinoma in situ in breast cancer screening. Eur J Cancer 2003;39:1746-54.
44. Elmore JG, Nakano CT, Koepsell TD, Desnick LM, D'Orsi CJ, Ransohoff DF. International variation in screening mammography interpretations in community-based programs. J Natl Cancer Inst 2003;95:1384-93.
45. Smith-Bindman R, Chu PW, Miglioretti DL, et al. Comparison of screening mammography in the United States and the United Kingdom. JAMA 2003;290:2129-37.
46. Smith-Bindman R, Kerlikowske KP. Optimal recall rates following mammography [letter]. JAMA 2004;291:821-22.
47. Sant M, Allemani G, Berrino F, et al. Breast cancer survival in Europe and the United States: a population-based study. Cancer 2004;100:715-22.
48. Smith RA, Saslow D, Sawyer KA, et al. American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin 2003;53:141-69.
49. Braun S, Tripathy D, Gralow J, Rubin E. American Society of Breast Disease policy statement on screening mammography. Available at http://www.asbd.org, 2002.